This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AIG CLH PAY PHM TOL


Stock Comments / EPS Changes

Adobe Systems (ADBE) price target was increased at UBS. Reflects seasonality and deepening migration to a subscription model. Twelve-month price target is $80. Buy rating.

American Eagle (AEO) numbers were cut at Nomura. Twelve-month price target is $13. Estimates were also reduced, as the company is facing increased price competition, Nomura said. Neutral rating.

Boeing (BA) price target was lowered at UBS. Incorporates lower FCF forecast as well as a higher pension deficit, UBS said. Twelve-month price target is $127. Neutral rating.

GT Advanced Tech (GTAT) price target was increased at UBS. Driven by announcement of $336 million contract to Cosmos Chemical, UBS said. Twelve-month price target is $20. Buy rating.

Marsh & McLennan (MMC) numbers were boosted at Nomura. Twelve-month price target is now $49. Estimates were also upped, following the company's update investor day. Neutral rating.

RSP Permian (RSPP) price target was increased at UBS. Still offers upside through potential upward EUR revisions for its core acreage and operational efficiency gains, UBS said. Twelve-month price target is $30. Buy rating.

Spectra Energy Partners (SEP) price target, EPS estimates were raised at Jefferies. Incorporating adjustments from acquisition all of SE's remaining US Transmission & Liquids assets, Jefferies said. Twelve-month price target is $47. Hold rating.

Taubman Centers (TCO) price target, EPS estimates were raised at Jefferies. Still owners of high quality assets, despite worry in retail sector, Jefferies said. Twelve-month price target is $67. Hold rating.

VMWare (VMW) was added to the US Focus List at Credit Suisse. Twelve-month price target is $130. Company has a dominant and highly defensible competitive position, Credit Suisse said.

Walgreen (WAG) price target was raised at UBS. Driven by specialty pharma tax inversion playbook to pharma services, UBS said. Twelve-month price target is $90. Buy rating.

Wynn (WYNN) estimates, price target were raised at Citigroup. Twelve-month price target is $277. Estimates also were increased, as Macau and Las Vegas should drive growth, Citigroup said. Buy rating.

Follow TheStreet on Twitter and become a fan on Facebook

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AIG $56.73 -1.40%
PAY $36.02 -0.41%
AAPL $127.06 -0.42%
FB $84.15 1.30%
GOOG $536.76 0.26%

Markets

DOW 17,984.95 -49.98 -0.28%
S&P 500 2,100.38 -0.02 -0.00%
NASDAQ 5,018.49 +23.8880 0.48%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs